Can decreased lung function be used as a diabetes predictor?

Product may offer simpler solution to hypoglycemia over intramuscular injections.

Mrs. O’Doole is a 34-year-old of Irish descent. She works as florist and is married with three children. She arrives at your clinic for her annual wellness exam. Her blood pressure is 130/84 mmHg, pulse 65, BMI 24 kg/m2 and her physical exam is notable for acne and mild hirsutism. Her only current medication is oral birth control pills. She recalls starting OCP, 15 years prior, due to irregular menses. What clinical diagnosis would suggest screening Mrs. O'Doole for type 2 diabetes? Follow the link to answer.

Since recent developments in the use of SGLT-2 inhibitors, are you positive or negative in recommending to your patients? Follow the link to respond.

Consider protein intake in addition to counting carbohydrates when calculating insulin doses.

In part two of this discussion, hosted by Diabetes in Control Publisher Steve Freed, Dr. Fetterolf continues his explanation of the best treatments for diabetic foot ulcers and the additional challenges that patients with diabetes face.

In this week's Homerun Slides, the cardiovascular benefits of pioglitazone.

Impaired glucose tolerance (IGT) and impaired fasting glycemia (IFG) are categorized as stages in the natural history of disordered carbohydrate metabolism. They occur in all individuals as they progress from normal to diabetes, but since the transition through these states is rapid in type 1 diabetes, they are rarely identified in such individuals. Therefore, nearly all of the literature dealing with IGT and IFG is concerned with issues relating to type 2 diabetes, such as risk of developing type 2 diabetes and CVD.

Some think you can’t be too rich or too thin. A stylish female, type 2 diabetes, 46 years of age came into the office (a weight loss clinic) for a follow up. Everyone was telling her how great she looked. She said she was feeling great and excited because she could fit into clothes she couldn’t fit in the past few years. She lost 9 pounds in three months. She had not been self monitoring her glucose. She was thrilled, but her doctor wasn’t so thrilled, at least not yet. He was concerned her glucose was elevated.

It has been a few years since Dr. Steven Nissan shook the diabetes world apart with his scathing review of the TZDs, pioglitazone and rosiglitizone. Many professionals blame him for the demise of rosiglitizone and the almost-death of pioglitazone, because of his comments on heart problems caused by the class …